3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase NA
1
Phase 2/3
1
Phase 2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Pancreatic Neoplasms
10
Neoplasms
9
Ovarian Neoplasms
8
Neoplasm Metastasis
8
Squamous Cell Carcinoma of Head and Neck
6
Leukemia, Myeloid, Acute
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lung Neoplasms
5
Leukemia
5
Glioblastoma
5
Colorectal Neoplasms
5
Stomach Neoplasms
4
Neuroblastoma
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Head and Neck Neoplasms
4
Fallopian Tube Neoplasms
4
Central Nervous System Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Brain Neoplasms
4
Recurrence
3
Gliosarcoma
3
Esophageal Neoplasms
3
Breast Neoplasms
3
Astrocytoma
3
Advanced Solid Tumors
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Mesothelioma, Malignant
2
Interventions
pembrolizumab
24
Paclitaxel
20
Carboplatin
19
Taxes
7
temsirolimus
6
Trastuzumab
6
Topotecan
5
Radiotherapy
5
Cisplatin
5
atezolizumab
4
Specimen Handling
4
Nivolumab
4
Magnetic Resonance Spectroscopy
4
Ipilimumab
4
Gemcitabine
4
Docetaxel
4
Biopsy
4
Bevacizumab
4
olaparib
3
lenvatinib
3
dostarlimab
3
Sirolimus
3
Pemetrexed
3
Irinotecan
3
Interleukin-12 Subunit p35
3
Fulvestrant
3
Cetuximab
3
Albumin-Bound Paclitaxel
3
spartalizumab
2
gedatolisib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Endometrial Neoplasms
×
Drug Therapy
×
Clear all
NCT05143970
2026-03-20
CHANCES
Institut Paoli-Calmettes
Phase 1
Recruiting
27 enrolled